At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
buprenorphinedrug
Likely dose
buprenorphine 0.2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influence of Cyclosporine on Buprenorphine Disposition
In Brief
A clinical study evaluating buprenorphine for Healthy. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The determine the effect of cyclosporine on buprenorphine disposition
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedJul 2012
Primary CompletionDec 2016
TodayJul 2026
First PostedJul 24, 2012
Enrollment StartApr 1, 2012
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 13.9 years ago
Interventions
buprenorphinedrug
Session 1 Intravenous buprenorphine: 0.2 mg over 1 hr Session 2 Sublingual buprenorphine: 2 mg Session 3 Intravenous buprenorphine 0.2 mg over 1 hr beginning 1 hr after starting cyclosporine Session 4 Sublingual buprenorphine: 2 mg after cyclosporine.